Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Operating Leases (2021 - 2022)

Historic Operating Leases for Usana Health Sciences (USNA) over the last 2 years, with Q1 2022 value amounting to $7.1 million.

  • Usana Health Sciences' Operating Leases fell 1782.73% to $7.1 million in Q1 2022 from the same period last year, while for Jan 2022 it was $7.1 million, marking a year-over-year decrease of 1782.73%. This contributed to the annual value of $7.1 million for FY2022, which is 1782.73% down from last year.
  • As of Q1 2022, Usana Health Sciences' Operating Leases stood at $7.1 million, which was down 1782.73% from $8.6 million recorded in Q1 2021.
  • Usana Health Sciences' Operating Leases' 5-year high stood at $8.6 million during Q1 2021, with a 5-year trough of $7.1 million in Q1 2022.